| Accession | Title | Sample type | Organism(s) | Ch | Platform | Series | Supplementary | Contact | Release date |
|---|---|---|---|---|---|---|---|---|---|
 Filter
|
RNA
|
May 01, 2023
|
|||||||
| GSM4544016 |
DMSO vs GSK126 treatment of HT1197 cells
|
RNA | 2 | Sooryanarayana Varambally | May 01, 2023 | ||||
| GSM4544017 |
DMSO vs GSK126 treatment of HT1376 cells
|
RNA | 2 | Sooryanarayana Varambally | May 01, 2023 | ||||
| GSM4544018 |
DMSO vs GSK126 treatment of T24 cells
|
RNA | 2 | Sooryanarayana Varambally | May 01, 2023 | ||||
| GSM4544019 |
DMSO vs GSK126 treatment of 5637 cells
|
RNA | 2 | Sooryanarayana Varambally | May 01, 2023 | ||||
| GSM6927975 |
InVitro_HSC-3_EGFR-WT_NoSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927976 |
InVitro_HSC-3_EGFR-WT_WithSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927977 |
InVitro_HSC-3_HER2_WithSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927978 |
InVitro_HSC-3_EGFR-KO_WithSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927979 |
InVitro_SAS_EGFR-WT_NoSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927980 |
InVitro_SAS_EGFR-WT_WithSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927981 |
InVitro_SAS_HER2_WithSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM6927982 |
InVitro_SAS_EGFR-KO_WithSerum
|
RNA | 1 | Akinobu Ota | May 01, 2023 | ||||
| GSM2601653 |
WAT_control_1
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601654 |
WAT_control_2
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601655 |
WAT_control_3
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601656 |
WAT_control_4
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601657 |
WAT_control_5
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601658 |
WAT_control_6
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601659 |
WAT_control_7
|
RNA | 1 | Christophe O Soulage | May 01, 2023 | ||||
| GSM2601660 |
WAT_control_8
|
RNA | 1 | Christophe O Soulage | May 01, 2023 |
